Advertisement
YOU ARE HERE: LAT HomeCollectionsRanexa Drug
IN THE NEWS

Ranexa Drug

FEATURED ARTICLES
BUSINESS
December 10, 2003 | From Bloomberg News
CV Therapeutics Inc. needs to conduct more studies on its Ranexa drug before it can be used to treat chest pain, a Food and Drug Administration advisory panel said. The Palo Alto biotechnology company is seeking approval to sell Ranexa for treating angina, the pain caused when the heart muscle is deprived of oxygen. The panel agreed with the FDA's staff, which Monday recommended more tests because of concerns over how Ranexa affects heart rhythms.
ARTICLES BY DATE
HEALTH
December 5, 2005 | Linda Marsa, Special to The Times
WELL-KNOWN for the crushing pain they can produce in the chest, heart attacks don't usually occur more than a few times. Angina pain, however, can be just as intense -- and sufferers can be doubled over in agony several times a week. Although the cardiac condition is not fatal, the underlying cause makes it more likely that sufferers will have a heart attack.
Advertisement
HEALTH
December 5, 2005 | Linda Marsa, Special to The Times
WELL-KNOWN for the crushing pain they can produce in the chest, heart attacks don't usually occur more than a few times. Angina pain, however, can be just as intense -- and sufferers can be doubled over in agony several times a week. Although the cardiac condition is not fatal, the underlying cause makes it more likely that sufferers will have a heart attack.
BUSINESS
December 10, 2003 | From Bloomberg News
CV Therapeutics Inc. needs to conduct more studies on its Ranexa drug before it can be used to treat chest pain, a Food and Drug Administration advisory panel said. The Palo Alto biotechnology company is seeking approval to sell Ranexa for treating angina, the pain caused when the heart muscle is deprived of oxygen. The panel agreed with the FDA's staff, which Monday recommended more tests because of concerns over how Ranexa affects heart rhythms.
BUSINESS
December 9, 2003 | From Times Staff and Wire Reports
The Dow Jones industrial average made a strong run for the 10,000 mark Monday but fell a few dozen points short. In currency trading, the dollar continued to sink to multi-year lows against the euro and other major currencies. The stock market had a generally bullish tone awaiting Federal Reserve policymakers' meeting today. The central bank is expected to keep its benchmark short-term interest rate at 1% to give the economy more time to gain momentum.
Los Angeles Times Articles
|